Skip to main content
Back
Watch Compare

Finch Therapeutics Group, Inc.

Data quality: 100%
Also listed as FNCHQ OTC
FNCH
OTC Manufacturing Chemicals
$9.20
$0.00 (0.00%)
Mkt Cap: 14.77 M
Price
$9.20
Mkt Cap
14.77 M
Day Range
$5.01 — $11.91
52-Week Range
$2.00 — $16.10
Volume
71,791
Open $11.90
50D / 200D Avg
$12.77
27.95% below
50D / 200D Avg
$12.96
29.01% below

Quick Summary

Key Takeaways

Negative free cash flow of -18.04 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-87.57%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-85.20%
Below sector avg (-53.41%)
ROIC-35.14%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio3.87
Interest CoverageN/A

Valuation

PE (TTM)
-1.04
Above sector avg (-1.48)
P/B Ratio1.04
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -1.0 -1.5
P/B 1.0 1.6
ROE % -85.2 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -87.57% Revenue Growth (3Y) -92.40%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -14.17 M
ROE -85.20% ROA -29.62%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -18.04 M
ROIC -35.14% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.87
Interest Coverage N/A Asset Turnover 0.00
Working Capital 12.82 M Tangible Book Value 14.22 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.04 Forward P/E N/A
P/B Ratio 1.04 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -122.12%
Market Cap 14.77 M Enterprise Value -1.26 M
Per Share
EPS (Diluted TTM) -8.80 Revenue / Share 0.00
FCF / Share -11.24 OCF / Share -11.24
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 127.35%
SBC-Adj. FCF -19.60 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2023 FY2022 FY2021
Revenue 107,000.0 861,000.0 18.53 M
Net Income -74.75 M -114.65 M -58.16 M
EPS (Diluted) -46.59 -2.40 —
Gross Profit — — —
Operating Income -83.86 M -115.59 M -59.99 M
EBITDA — — —
R&D Expenses 7.20 M 57.89 M 57.28 M
SG&A Expenses — — —
D&A 1.52 M 5.51 M 2.30 M
Interest Expense — — —
Income Tax -3.46 M 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2023 FY2022 FY2021
Total Assets 55.37 M 162.94 M 225.37 M
Total Liabilities 32.49 M 67.23 M 23.15 M
Shareholders' Equity 22.89 M 95.71 M 202.22 M
Total Debt 0.0 15.00 M 0.0
Cash & Equivalents 25.12 M 71.04 M 133.48 M
Current Assets 25.85 M 74.55 M 142.55 M
Current Liabilities 4.08 M 14.69 M 14.79 M